Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 186,426 | 193,241 | 202,771 | 182,790 | 174,116 |
| Receivables | 105,844 | 148,999 | 90,098 | 93,156 | 83,320 |
| Inventories | 17,394 | 17,358 | 19,595 | 15,498 | 15,614 |
| TOTAL | $315,543 | $363,238 | $318,532 | $296,311 | $277,888 |
| Non-Current Assets | |||||
| PPE Net | 19,491 | 19,629 | 19,555 | 19,760 | 18,988 |
| Intangibles | 268,723 | 285,518 | 302,314 | 319,109 | 335,904 |
| Other Non-Current Assets | 88,320 | 73,418 | 73,334 | 10,885 | 11,061 |
| TOTAL | $376,534 | $378,565 | $395,203 | $349,754 | $365,953 |
| Total Assets | $692,077 | $741,803 | $713,735 | $646,065 | $643,841 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48,353 | 48,135 | 47,919 | 47,705 | 47,495 |
| Accounts payable and accrued liabilities | 4,189 | 7,730 | 7,543 | 8,666 | 10,016 |
| Accrued Expenses | 226,210 | 212,315 | 170,610 | 173,047 | 181,210 |
| TOTAL | $279,566 | $268,973 | $226,843 | $230,168 | $239,451 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,666 | 73,832 | 85,944 | 98,006 | 110,019 |
| Other Non-Current Liabilities | 147,917 | 147,904 | 147,882 | 147,856 | 108,340 |
| TOTAL | $209,583 | $221,736 | $233,826 | $245,862 | $218,359 |
| Total Liabilities | $489,149 | $490,709 | $460,669 | $476,030 | $457,810 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,378 | 34,569 | 35,564 | 35,248 | 34,756 |
| Common Shares | 36 | 36 | 36 | 35 | 35 |
| Retained earnings | -256,342 | -231,308 | -239,354 | -312,197 | -333,147 |
| Other shareholders' equity | 139 | -480 | 0 | 0 | 0 |
| TOTAL | $202,928 | $251,094 | $253,066 | $170,035 | $186,031 |
| Total Liabilities And Equity | $692,077 | $741,803 | $713,735 | $646,065 | $643,841 |